Literature DB >> 28675784

A compendium of ERK targets.

Evrim B Ünal1,2, Florian Uhlitz1,2, Nils Blüthgen1,2,3.   

Abstract

The RAF-MEK-ERK cascade is one of the most studied signaling pathways as it controls many vital cellular programs. There has been an immense amount of effort to determine ERK target proteins involved in regulating these programs. Classical biochemical and genetic approaches have elicited hundreds of direct ERK substrates, and with the advent of phospho-proteomic technologies, numerous studies have expanded the number of ERK target proteins. Here, we compile a comprehensive ERK target phospho-site archive, in which we gathered information from various research studies, and we provide this archive as an online database to form a searchable compendium of ERK targets.
© 2017 Federation of European Biochemical Societies.

Entities:  

Keywords:  ERK targets; MAP kinase signaling; RAF-MEK-ERK; phosphorylation

Mesh:

Substances:

Year:  2017        PMID: 28675784     DOI: 10.1002/1873-3468.12740

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  36 in total

1.  KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism.

Authors:  Angelina V Vaseva; Devon R Blake; Thomas S K Gilbert; Serina Ng; Galen Hostetter; Salma H Azam; Irem Ozkan-Dagliyan; Prson Gautam; Kirsten L Bryant; Kenneth H Pearce; Laura E Herring; Haiyong Han; Lee M Graves; Agnieszka K Witkiewicz; Erik S Knudsen; Chad V Pecot; Naim Rashid; Peter J Houghton; Krister Wennerberg; Adrienne D Cox; Channing J Der
Journal:  Cancer Cell       Date:  2018-11-12       Impact factor: 31.743

2.  When More Is Less: Dual Phosphorylation Protects Signaling Off State against Overexpression.

Authors:  Franziska Witzel; Nils Blüthgen
Journal:  Biophys J       Date:  2018-08-23       Impact factor: 4.033

3.  Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma Cells.

Authors:  Joel Basken; Scott A Stuart; Andrew J Kavran; Thomas Lee; Christopher C Ebmeier; William M Old; Natalie G Ahn
Journal:  Mol Cell Proteomics       Date:  2017-12-18       Impact factor: 5.911

Review 4.  ERK signalling: a master regulator of cell behaviour, life and fate.

Authors:  Hugo Lavoie; Jessica Gagnon; Marc Therrien
Journal:  Nat Rev Mol Cell Biol       Date:  2020-06-23       Impact factor: 94.444

5.  Rewiring of RSK-PDZ Interactome by Linear Motif Phosphorylation.

Authors:  Gergő Gógl; Beáta Biri-Kovács; Fabien Durbesson; Pau Jane; Yves Nomine; Camille Kostmann; Viktória Bilics; Márton Simon; Attila Reményi; Renaud Vincentelli; Gilles Trave; László Nyitray
Journal:  J Mol Biol       Date:  2019-02-03       Impact factor: 5.469

6.  Nfya-1 functions as a substrate of ERK-MAP kinase during Caenorhabditis elegans vulval development.

Authors:  Segen Aklilu; Michelle Krakowiak; Abena Frempong; Katherine Wilson; Christy Powers; Douglas Fantz
Journal:  Cells Dev       Date:  2021-11-24

Review 7.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

Review 8.  RAF kinase dimerization: implications for drug discovery and clinical outcomes.

Authors:  Tilman Brummer; Campbell McInnes
Journal:  Oncogene       Date:  2020-04-08       Impact factor: 9.867

9.  Combination of ERK2 and STAT3 Inhibitors Promotes Anticancer Effects on Acute Lymphoblastic Leukemia Cells.

Authors:  Ewa Jasek-Gajda; Halina Jurkowska; MaŁgorzata JasiŃska; Jan A Litwin; Grzegorz J Lis
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

Review 10.  A review of the biological and clinical implications of RAS-MAPK pathway alterations in neuroblastoma.

Authors:  Vid Mlakar; Edouard Morel; Simona Jurkovic Mlakar; Marc Ansari; Fabienne Gumy-Pause
Journal:  J Exp Clin Cancer Res       Date:  2021-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.